Congress is beginning to push back on pharmaceutical benefit managers (PBMs). PRI’s Wayne Winegarden tells NTD News that a large problem lies in the lack of transparency in the drug pricing system. Reforming the PBM system could reduce costs for patients.
Wayne Winegarden on NTD News to Discuss Congress Pushing Back on Pharmaceutical Benefit Managers
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.